McNulty v. Taser International Inc.

217 F. Supp. 2d 1058, 2002 U.S. Dist. LEXIS 17125, 2002 WL 1940252
CourtDistrict Court, C.D. California
DecidedJuly 29, 2002
DocketSACV 01-0395 DOC
StatusPublished
Cited by3 cases

This text of 217 F. Supp. 2d 1058 (McNulty v. Taser International Inc.) is published on Counsel Stack Legal Research, covering District Court, C.D. California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
McNulty v. Taser International Inc., 217 F. Supp. 2d 1058, 2002 U.S. Dist. LEXIS 17125, 2002 WL 1940252 (C.D. Cal. 2002).

Opinion

ORDER

MARKMAN HEARING CLAIM INTERPRETATION AND ORDER DENYING PLAINTIFF’S MOTION FOR SUMMARY ADJUDICATION AND GRANTING DEFENDANT’S MOTION FOR SUMMARY JUDGMENT

CARTER, District Judge.

Before the Court is Plaintiff James F. McNulty’s motion for summary adjudication of the issue of patent infringement and Defendant Taser International Inc.’s cross-motion for summary judgment. Beginning on March 19, 2002, the parties presented evidence in a proceeding commonly known as a Markman hearing to facilitate claim construction of claim 39 of United States Patent 5,193,048 (’048 patent). After the close of the Markman hearing the Court requested that both parties file motions for summary judgment. The parties had presented extensive evidence at the Markman hearing regarding both the proper interpretation of the patent and the alleged infringement . of the ’048 patent by Defendant’s products. Therefore, the parties agreed that motions for summary adjudication of infringement would be appropriate and would allow the Court to determine both the claim interpretation and the infringement issue at the same time. The parties waived their rights to additional oral argument. Thus, upon consideration of all papers submitted in this matter, the evidence and oral argument presented at the Markman hearing, and for the reasons set forth below, the Court DENIES Plaintiffs motion for summary judgment and GRANTS Defendant’s motion for summary judgment.

I. BACKGROUND

Plaintiff James F. McNulty, Jr. filed his original complaint in this action on April 9, 2001, alleging infringement of patent ’048. The ’048 patent refers to a nonlethal device with an electric charge that causes a contact shock, commonly referred to as a type of stun gun. Patent ’048 was issued to Dennis R. Kaufman and William A. Keeley in March 1993 and was subsequently assigned to Richard Bass. Currently, Bass’ company, Electronic Defense Technologies, manufactures stun guns (some of which use the ’048 patent), including a model with the product name Ultronll. 1

Plaintiffs rights to the ’048 patent were acquired pursuant to a license agreement with Bass, which became effective upon both parties’ signatures, on February 7, 2001. Plaintiff paid $1000 in exchange for an exclusive, but limited, right in the ’048 patent. The grant applies only when the patent is used in conjunction with one of two other specified patents. Bass retains all rights when the ’048 patent is used in *1061 any other manner. This Court previously found that Plaintiff is an exclusive licensee, and not an assignee, under the agreement and ordered Bass joined as an involuntary plaintiff to effectuate the suit. (Order Jan. 7, 2002).

Subsequent to the license agreement, and in accordance with its express terms, Plaintiff granted a sublicense in the ’048 patent to Barnet Resnick on February 15, 2001. In the agreement, Plaintiff reserved the right to prosecute actions against in-fringers and agreed to a specific formula for sharing any payments received from such litigation. Resnick has not joined the suit voluntarily and the Court previously denied a motion to join him involuntarily. (See Order Jan. 7, 2002).

Defendant Taser International, Inc. (Ta-ser) is a corporation that manufactures stun gun products that Plaintiff contends infringe ’048 patent. Specifically, Plaintiff alleges that three of Taser’s products, the U34000, the M-18L and the M-26, infringe claim 39 of the ’048 patent.

II. LEGAL STANDARD

Claim interpretation is a matter of law, Markman v. Westview Instruments, Inc., 52 F.3d 967, 979 (Fed.Cir.1995) (en banc), and is thus amenable to summary judgment, Phonometrics Inc. v. N. Telecom Inc., 133 F.3d 1459, 1463 (Fed.Cir.1998). The Court may resolve a claim interpretation dispute pursuant to a traditional summary judgment motion, even though the analysis involves both issues of law and questions of fact. Id. at 1463-64. Many recent courts, however, have chosen to have a claim interpretation hearing, or Markman hearing, to facilitate the claim interpretation process. E.g., Ethicon Endo-Surgery, Inc. v. United States Surgical Corp., 93 F.3d 1572, 1577 (Fed.Cir.1996). This Court conducted a Markman hearing from March 19, 2002 to March 21, 2002.

The parties were given the opportunity to present evidence related to Defendant’s products, in addition to evidence that only applies to claim interpretation. The parties have now filed summary judgment motions to resolve both the claim interpretation and the issue of infringement in one ruling by the Court. Thus, the standard for summary judgment motions applies. Summary judgment is proper if “the pleadings, depositions, answers to ' interrogatories, and admissions on file, together with the affidavits, if any, show that there is no genuine issue as to any material fact and that the moving party is entitled to judgment as a matter of law.” Fed. R.Civ.P. 56(c).

III. CLAIM INTERPRETATION

A. Governing Law

A patent infringement analysis involves two separate steps: (1) interpretation of the asserted claims, and (2) comparing the claims to the accused device. Markman, 52 F.3d at 976. Three principal sources are used in claim interpretation, the claims, the specification, and the prosecution history. Id. at 979 (quoting Unique Concepts, Inc. v. Brown, 939 F.2d 1558, 1561 (Fed.Cir.1991)). Claim interpretation begins with the language of the claim. K-2 Corp. v. Salomon S.A., 191 F.3d 1356, 1362 (Fed.Cir.1999). As a general rule, terms in a claim are to be given their ordinary and accustomed meaning. Id. The terms must, however, be read in the context of the patent specification. E.g., Advanced Cardiovascular Sys., Inc. v. Scimed Life Sys., Inc., 261 F.3d 1329, 1338 (Fed.Cir.2001) (quoting Markman, 52 F.3d at 979). The specification includes a written description of the invention which explains the invention and defines key terms. Markman, 52 F.3d at 979. Additionally, the court should also consider the prosecution history, which is the “undis *1062 puted public record” of the patent. Markman, 52 F.3d at 980.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

McNulty v. Taser International, Inc.
106 F. App'x 15 (Federal Circuit, 2004)
J.R. Simplot Co. v. Rycair, Inc.
67 P.3d 36 (Idaho Supreme Court, 2003)
Intex Recreation Corp. v. Metalast, S.A. Sociedad Unipersonal
245 F. Supp. 2d 65 (District of Columbia, 2003)

Cite This Page — Counsel Stack

Bluebook (online)
217 F. Supp. 2d 1058, 2002 U.S. Dist. LEXIS 17125, 2002 WL 1940252, Counsel Stack Legal Research, https://law.counselstack.com/opinion/mcnulty-v-taser-international-inc-cacd-2002.